Clinical trial · Interventional
Lymphedema Treatment in Head and Neck Cancer Patients
Evaluation of External Lymphedema Treatment on Pharyngeal Pressure in Head and Neck Cancer Patients
NCT04276454CI-TRIAL-00046611withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Per investigator's request.
Summary
Brief summary (as posted)
The purpose of this research is to evaluate the result of treatment for neck lymphedema on throat pressure in patients who have received radiation therapy for head and neck cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Flexitouch Plus system | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Single arm
- interventionNames
- Device: Flexitouch Plus system
Primary outcomes (1)
- measure
- Internal lymphedema measurement
- timeFrame
- 2 hours
- description
- The pressure in the throat will be measured using a device called high-resolution manometry before and after wearing a treatment jacket (Flexitouch plus device).
Secondary outcomes (1)
- measure
- External lymphedema measurement
- timeFrame
- 2 hours
- description
- Neck circumference measurement will be done using standard tape measure before and after wearing a treatment jacket (Flexitouch plus device).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with tumors of the nasopharynx, oral cavity, oropharynx, hypopharynx, or larynx who will have radiation therapy as part of their treatment plan * Both male and females * 18 to 100 years of age Exclusion Criteria: * Significant surgical resection of pharyngeal constrictor muscles * Patients with persistent or recurrent disease * Patients who have contraindications to use Flexitouch Plus device
References
Publications (0)
Data not yet available
No reference posted for this study.